|
CA2411101C
(en)
|
2000-06-05 |
2018-01-16 |
Brigham And Women's Hospital, Inc. |
A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US8981061B2
(en)
|
2001-03-20 |
2015-03-17 |
Novo Nordisk A/S |
Receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
|
|
US8008012B2
(en)
*
|
2002-01-24 |
2011-08-30 |
Health Discovery Corporation |
Biomarkers downregulated in prostate cancer
|
|
CA2992643C
(en)
*
|
2002-03-13 |
2019-06-18 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
|
AU2003295598B2
(en)
|
2002-11-15 |
2009-12-24 |
Genomic Health, Inc. |
Gene expression profiling of EGFR positive cancer
|
|
ES2609234T3
(es)
|
2003-06-24 |
2017-04-19 |
Genomic Health, Inc. |
Predicción de la probabilidad de recidiva de cáncer
|
|
US20130122504A1
(en)
*
|
2011-11-14 |
2013-05-16 |
Lars Dyrskjot Andersen |
Expression Levels of COL4A3BP and other Markers Correlating with Progression or Non-Progression of Bladder Cancer
|
|
CA2563074C
(en)
|
2004-04-09 |
2014-05-20 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
|
WO2006044017A2
(en)
*
|
2004-08-13 |
2006-04-27 |
Jaguar Bioscience Inc. |
Systems and methods for identifying diagnostic indicators
|
|
US8747867B2
(en)
|
2004-09-30 |
2014-06-10 |
Ifom Fondazione Instituto Firc Di Oncologia Molecolare |
Cancer markers
|
|
WO2008125791A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Ifom Fondazione Istituto Firc Di Oncologia Molecolare |
Cancer markers
|
|
GB0421838D0
(en)
|
2004-09-30 |
2004-11-03 |
Congenia S R L |
Cancer markers
|
|
US20060134243A1
(en)
*
|
2004-12-17 |
2006-06-22 |
Bionovo, Inc. |
Method of using extracts of epimedium species
|
|
US7482029B2
(en)
|
2005-04-01 |
2009-01-27 |
Bionovo, Inc. |
Composition for treatment of menopause
|
|
US20060252073A1
(en)
*
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
EP1907858A4
(en)
|
2005-06-13 |
2009-04-08 |
Univ Michigan |
COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
|
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
|
US20100029504A1
(en)
*
|
2007-01-16 |
2010-02-04 |
Phigenix, Inc. |
Detecting pax2 for the diagnosis of breast cancer
|
|
JP5129149B2
(ja)
*
|
2005-10-31 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌を処置および診断するための組成物および方法
|
|
US20070220621A1
(en)
*
|
2005-10-31 |
2007-09-20 |
Clarke Michael F |
Genetic characterization and prognostic significance of cancer stem cells in cancer
|
|
US7700136B2
(en)
*
|
2005-11-14 |
2010-04-20 |
Bionovo, Inc. |
Scutellaria barbata extract for the treatment of cancer
|
|
NZ593226A
(en)
|
2006-01-11 |
2012-10-26 |
Genomic Health Inc |
Gene expression markers (efnb2) for colorectal cancer prognosis
|
|
US8663635B2
(en)
|
2006-03-21 |
2014-03-04 |
The Regents Of The University Of California |
N-cadherin: target for cancer diagnosis and therapy
|
|
WO2007109347A2
(en)
*
|
2006-03-21 |
2007-09-27 |
The Regents Of The University Of California |
N-cadherin and ly6 e: targets for cancer diagnosis and therapy
|
|
US20100278821A1
(en)
*
|
2006-03-21 |
2010-11-04 |
The Regents Of The University Of California |
N-cadherin: target for cancer diagnosis and therapy
|
|
WO2007123772A2
(en)
|
2006-03-31 |
2007-11-01 |
Genomic Health, Inc. |
Genes involved in estrogen metabolism
|
|
US8535677B2
(en)
|
2006-06-06 |
2013-09-17 |
Oxford Biotherapeutics, Ltd. |
Antibody drug conjugate treatment of colorectal cancer
|
|
GB0611405D0
(en)
*
|
2006-06-09 |
2006-07-19 |
Univ Belfast |
FKBP-L: A novel inhibitor of angiogenesis
|
|
US20080050739A1
(en)
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
|
EP2589668A1
(en)
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Rare cell analysis using sample splitting and DNA tags
|
|
US8137912B2
(en)
|
2006-06-14 |
2012-03-20 |
The General Hospital Corporation |
Methods for the diagnosis of fetal abnormalities
|
|
WO2007147074A2
(en)
|
2006-06-14 |
2007-12-21 |
Living Microsystems, Inc. |
Use of highly parallel snp genotyping for fetal diagnosis
|
|
EP3796002B1
(en)
|
2006-07-14 |
2023-11-22 |
The Regents of The University of California |
Cancer biomarkers and methods of use thereof
|
|
ES2625259T3
(es)
*
|
2006-08-29 |
2017-07-19 |
Oxford Biotherapeutics Ltd |
Identificación de proteína asociada con carcinoma hepatocelular, glioblastoma y cáncer de pulmón
|
|
US20080187938A1
(en)
*
|
2006-09-22 |
2008-08-07 |
The Regents Of The University Of Michigan |
ALDH1 As A Cancer Stem Cell Marker
|
|
US8338109B2
(en)
|
2006-11-02 |
2012-12-25 |
Mayo Foundation For Medical Education And Research |
Predicting cancer outcome
|
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
EP2993473A1
(en)
*
|
2007-01-30 |
2016-03-09 |
Pharmacyclics, Inc. |
Methods for determining cancer resistance to histone deacetylase inhibitors
|
|
US20110178154A1
(en)
*
|
2007-02-06 |
2011-07-21 |
Birrer Michael J |
gene expression profile that predicts ovarian cancer subject response to chemotherapy
|
|
WO2008101118A2
(en)
|
2007-02-14 |
2008-08-21 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
A gene expression signature identifying pro-angiogenic genes in ovarian tumor endothelial cell isolates
|
|
GB0706658D0
(en)
*
|
2007-04-05 |
2007-05-16 |
Imp Innovations Ltd |
Breast cancer methods, medicaments and agents
|
|
EP2155248B1
(en)
|
2007-04-12 |
2015-06-10 |
The Brigham and Women's Hospital, Inc. |
Targeting abcb5 for cancer therapy
|
|
WO2008143795A1
(en)
*
|
2007-05-11 |
2008-11-27 |
Champions Biotechnology, Inc. |
Human mesenchymal chrondrosarcoma xenograft model and its use in chemosensitivity testing
|
|
US20100183514A1
(en)
*
|
2007-05-29 |
2010-07-22 |
President And Fellows Of Harvard College |
Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
|
|
JP2010528623A
(ja)
*
|
2007-06-01 |
2010-08-26 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
肺癌についての多重遺伝子予後診断アッセイ
|
|
JP5719591B2
(ja)
*
|
2007-06-08 |
2015-05-20 |
バイオジェン アイデック エムエー インコーポレイティドＢｉｏｇｅｎ Ｉｄｅｃ Ｉｎｃ． |
抗ｔｎｆ応答性または非応答性を予測するためのバイオマーカー
|
|
US20080319051A1
(en)
*
|
2007-06-22 |
2008-12-25 |
Bionovo, Inc. |
Liquiritigenin and derivatives as selective estrogen receptor beta agonists
|
|
US20090042818A1
(en)
*
|
2007-06-22 |
2009-02-12 |
Bionovo, Inc. |
Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
|
|
WO2009009739A2
(en)
*
|
2007-07-12 |
2009-01-15 |
Theracrine, Inc. |
Methods and compositions for facilitating cell death of cancer stem cells and for treating cancer
|
|
WO2009011911A2
(en)
*
|
2007-07-18 |
2009-01-22 |
The Johns Hopkins University |
Methods of detecting prostate cancer
|
|
WO2009018446A1
(en)
*
|
2007-08-01 |
2009-02-05 |
The Johns Hopkins University |
Esophageal cancer markers
|
|
WO2009021196A1
(en)
*
|
2007-08-08 |
2009-02-12 |
Bionovo, Inc. |
Extracts of ligustrum lucidum and uses thereof
|
|
AU2008296176A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Bionovo, Inc. |
Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof
|
|
AU2008296072A1
(en)
*
|
2007-09-07 |
2009-03-12 |
Bionovo, Inc. |
Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof
|
|
EP2190292A4
(en)
*
|
2007-09-07 |
2012-12-26 |
Bionovo Inc |
ESTROGENWIRKSAME EXTRACTS OF SCUTTELARIA BARBATA D. DON OF THE FAMILY LABIATAE AND ITS USES
|
|
JP2010539086A
(ja)
*
|
2007-09-07 |
2010-12-16 |
バイオノボ・インコーポレーテッド |
マメ科ファミリーのクズのエストロゲン性抽出物およびその使用
|
|
US8039227B2
(en)
*
|
2007-09-20 |
2011-10-18 |
University Of Louisville Research Foundation, Inc. |
Peptide biomarkers predictive of renal function decline and kidney disease
|
|
WO2009046118A1
(en)
*
|
2007-10-01 |
2009-04-09 |
The Children's Hospital Of Philadelphia |
Cancer susceptibility loci located at chromosome 6p22 and chromosome 20 for use in diagnostic and therapeutic methods
|
|
EP2210092B1
(en)
|
2007-10-19 |
2014-06-11 |
Rappaport Family Institute for Research in the Medical Sciences |
Compositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
|
|
US9808506B2
(en)
|
2007-10-19 |
2017-11-07 |
Rappaport Family Institute For Research In The Medical Sciences |
Compositions comprising semaphorins for the treatment of cancer and methods of selection thereof
|
|
WO2009148470A1
(en)
*
|
2007-10-25 |
2009-12-10 |
The Board Of Trustees Of Southern Illinois University |
Methods for diagnosing bowel disease
|
|
WO2009062104A2
(en)
*
|
2007-11-09 |
2009-05-14 |
Baylor College Of Medicine |
Aberrant expression of zinc transporter zip4 (slc39a4) significantly contributes to human pancreatic cancer pathogenesis and progression
|
|
US20090130118A1
(en)
*
|
2007-11-19 |
2009-05-21 |
Bionovo, Inc. |
Scutellaria barbata extract and combinations for the treatment of cancer
|
|
US20090130101A1
(en)
*
|
2007-11-19 |
2009-05-21 |
Bionovo, Inc. |
Anti-cancer therapy with an extract of scutellaria barbata
|
|
EP2222323A4
(en)
*
|
2007-11-19 |
2012-07-25 |
Bionovo Inc |
PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON
|
|
EP2219659A4
(en)
*
|
2007-11-19 |
2010-11-17 |
Bionovo Inc |
METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT
|
|
WO2009075799A2
(en)
*
|
2007-12-05 |
2009-06-18 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
|
KR101169127B1
(ko)
*
|
2008-01-15 |
2012-08-03 |
가톨릭대학교 산학협력단 |
비교유전자보합법을 이용한 간암 예후 진단방법 및진단키트
|
|
US20090274623A1
(en)
*
|
2008-01-30 |
2009-11-05 |
General Electric Company |
In vivo imaging agents for met receptor tyrosine kinase
|
|
WO2009111644A2
(en)
*
|
2008-03-05 |
2009-09-11 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating pancreatic cancer
|
|
WO2009114836A1
(en)
|
2008-03-14 |
2009-09-17 |
Genomic Health, Inc. |
Gene expression markers for prediction of patient response to chemotherapy
|
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
|
JP2011521619A
(ja)
*
|
2008-04-04 |
2011-07-28 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
腫瘍成長、血管新生および転移を妨害する癌標的に対する新規抗体
|
|
EP2274617A4
(en)
*
|
2008-04-10 |
2011-11-09 |
Massachusetts Inst Technology |
METHOD OF DETECTING AND USING MEDIUM-TREATMENT AID ON CANCER STEM CELLS
|
|
CA2721191A1
(en)
*
|
2008-04-14 |
2009-10-22 |
Bionovo, Inc. |
Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
|
|
WO2009132126A2
(en)
|
2008-04-22 |
2009-10-29 |
The Washington University |
Method for predicting risk of metastasis
|
|
WO2009137534A2
(en)
*
|
2008-05-06 |
2009-11-12 |
Bionovo, Inc. |
Estrogenic extracts for use in treating vaginal and vulvar atrophy
|
|
US8093000B2
(en)
*
|
2008-05-09 |
2012-01-10 |
The Regents Of The University Of California |
Methods for predicting and treating tumors resistant to drug, immunotherapy, and radiation
|
|
DK2568053T3
(da)
*
|
2008-05-12 |
2014-07-21 |
Genomic Health Inc |
Tests til forudsigelse af cancerpatienters respons på forskellige kemoterapeutiske behandlingsmuligheder
|
|
EP2285989B1
(en)
|
2008-05-15 |
2016-11-16 |
The University of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
|
CN101587125B
(zh)
*
|
2008-05-21 |
2013-07-24 |
林标扬 |
高表达癌症标记物和低表达组织器官标记物组合试剂盒
|
|
EP2806054A1
(en)
|
2008-05-28 |
2014-11-26 |
Genomedx Biosciences Inc. |
Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
|
|
US10407731B2
(en)
|
2008-05-30 |
2019-09-10 |
Mayo Foundation For Medical Education And Research |
Biomarker panels for predicting prostate cancer outcomes
|
|
CA2726982A1
(en)
*
|
2008-06-05 |
2009-12-10 |
Bionovo, Inc. |
Method of quantification of multiple bioactives from botanical compositions
|
|
US20090312437A1
(en)
*
|
2008-06-06 |
2009-12-17 |
Bionovo, Inc., A Delaware Corporation |
Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
|
|
EP2304630A1
(en)
*
|
2008-06-16 |
2011-04-06 |
Sividon Diagnostics GmbH |
Molecular markers for cancer prognosis
|
|
EP2304048A4
(en)
*
|
2008-06-17 |
2011-07-27 |
Univ Rochester |
TUMORSUPPRESSION ABOUT PLEXIN C1
|
|
ES2613841T3
(es)
*
|
2008-07-16 |
2017-05-26 |
Medical And Biological Laboratories Co., Ltd. |
Anticuerpo anti-CLCP1 humano y uso del mismo
|
|
EP2340027A4
(en)
*
|
2008-09-03 |
2012-04-04 |
Bionovo Inc |
METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
|
|
HUE031848T2
(en)
|
2008-09-20 |
2017-08-28 |
Univ Leland Stanford Junior |
Non-invasive diagnosis of fetal aneuploidy by sequencing
|
|
US8703920B2
(en)
*
|
2008-11-10 |
2014-04-22 |
The Regents Of The University Of California |
Fully human antibodies against N-cadherin
|
|
EP2687609B1
(en)
*
|
2008-11-10 |
2017-01-04 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Method for treating solid tumor
|
|
WO2010056662A1
(en)
*
|
2008-11-11 |
2010-05-20 |
University Of Washington |
Activated wnt-beta-catenin signaling in melanoma
|
|
US20110230372A1
(en)
*
|
2008-11-14 |
2011-09-22 |
Stc Unm |
Gene expression classifiers for relapse free survival and minimal residual disease improve risk classification and outcome prediction in pediatric b-precursor acute lymphoblastic leukemia
|
|
US11542328B2
(en)
|
2008-11-14 |
2023-01-03 |
The Brigham And Women's Hospital, Inc. |
Therapeutic and diagnostic methods relating to cancer stem cells
|
|
EP3978928A1
(en)
*
|
2008-11-14 |
2022-04-06 |
The Brigham and Women's Hospital, Inc. |
Therapeutic and diagnostic methods relating to cancer stem cells
|
|
WO2010056374A2
(en)
*
|
2008-11-17 |
2010-05-20 |
Veracyte, Inc. |
Methods and compositions of molecular profiling for disease diagnostics
|
|
US10236078B2
(en)
|
2008-11-17 |
2019-03-19 |
Veracyte, Inc. |
Methods for processing or analyzing a sample of thyroid tissue
|
|
US9495515B1
(en)
|
2009-12-09 |
2016-11-15 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
|
WO2010088386A1
(en)
*
|
2009-01-28 |
2010-08-05 |
University Of Notre Dame Du Lac |
Accelerated progression relapse test
|
|
EP2955235A3
(en)
*
|
2009-01-30 |
2016-03-02 |
Koninklijke Philips N.V. |
Methods for the subclassification of breast tumours
|
|
US9074258B2
(en)
|
2009-03-04 |
2015-07-07 |
Genomedx Biosciences Inc. |
Compositions and methods for classifying thyroid nodule disease
|
|
US8765383B2
(en)
*
|
2009-04-07 |
2014-07-01 |
Genomic Health, Inc. |
Methods of predicting cancer risk using gene expression in premalignant tissue
|
|
DK2421898T3
(en)
|
2009-04-20 |
2016-05-30 |
Oxford Biotherapeutics Ltd |
Cadherin-17 SPECIFIC ANTIBODIES
|
|
CA2759671A1
(en)
*
|
2009-04-28 |
2010-11-11 |
Bionovo, Inc. |
Method of reducing fat accumulation and inducing weight loss
|
|
SG10201401722XA
(en)
*
|
2009-05-01 |
2014-08-28 |
Genomic Health Inc |
Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer andresponse to chemotherapy
|
|
CA2760589C
(en)
*
|
2009-05-01 |
2019-08-20 |
Joseph Collard |
Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
|
|
US8669057B2
(en)
|
2009-05-07 |
2014-03-11 |
Veracyte, Inc. |
Methods and compositions for diagnosis of thyroid conditions
|
|
ES2361808B8
(es)
*
|
2009-05-25 |
2012-11-29 |
Consejo Superior De Investigaciones Cientificas (Csic) 20% |
Método de obtención de datos útiles para el diagnóstico o el pronóstico del cáncer colorrectal.
|
|
JP2012529914A
(ja)
*
|
2009-06-15 |
2012-11-29 |
カーディオ ディーエクス インコーポレイティッド |
冠動脈疾患リスクの判定法
|
|
EP2445531A4
(en)
*
|
2009-06-24 |
2013-04-24 |
Lpath Inc |
PROCESS FOR INCREASED NEURONAL DIFFERENTIATION USING ANTIBODIES TO LYSOPHOSPHACIDIC ACID
|
|
EP2270510A1
(en)
*
|
2009-07-02 |
2011-01-05 |
EMBL (European Molecular Biology Laboratory) |
Diagnostic method for predicting the risk of cancer recurrence based on Histone macroH2A isoforms
|
|
US20110039788A1
(en)
*
|
2009-07-10 |
2011-02-17 |
University Of Miami |
Compositions, methods and kits for detecting and treating cancer
|
|
WO2011015379A1
(en)
*
|
2009-08-05 |
2011-02-10 |
Nexigen Gbmh |
Human hcv-interacting proteins and methods of use
|
|
US20120156312A1
(en)
*
|
2009-09-01 |
2012-06-21 |
Trustees Of Dartmouth College |
Compositions for Inhibiting Growth of Cancer Stem Cells
|
|
US20120157342A1
(en)
*
|
2009-09-02 |
2012-06-21 |
Shinji Mizuarai |
Predictive biomarkers useful for cancer therapy mediated by a wee1 inhibitor
|
|
US8728730B2
(en)
*
|
2009-09-03 |
2014-05-20 |
Genentech, Inc. |
Methods for treating, diagnosing, and monitoring rheumatoid arthritis
|
|
EP2475784A1
(en)
*
|
2009-09-08 |
2012-07-18 |
Ramot at Tel-Aviv University Ltd. |
Methods of diagnosing amyotrophic lateral sclerosis (als)
|
|
WO2011054359A2
(en)
|
2009-11-06 |
2011-05-12 |
University Of Copenhagen |
Method for early detection of cancer
|
|
CA3043089A1
(en)
*
|
2009-11-23 |
2011-05-26 |
Genomic Health, Inc. |
Methods to predict clinical outcome of cancer
|
|
EP2507396A4
(en)
*
|
2009-12-01 |
2013-06-19 |
Precision Therapeutics Inc |
MULTI-MEDICATION RESPONSE MARKERS FOR BREAST CANCER CELLS
|
|
US10446272B2
(en)
|
2009-12-09 |
2019-10-15 |
Veracyte, Inc. |
Methods and compositions for classification of samples
|
|
CA2782366A1
(en)
|
2009-12-16 |
2011-07-14 |
Opko Curna, Llc |
Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
|
|
GB0922085D0
(en)
*
|
2009-12-17 |
2010-02-03 |
Cambridge Entpr Ltd |
Cancer diagnosis and treatment
|
|
WO2011078301A1
(ja)
|
2009-12-25 |
2011-06-30 |
ファーマロジカルズ・リサーチ プライベート リミテッド |
Nog樹立癌細胞株が移植された非ヒト動物モデルを用いた抗癌剤ターゲット探索及びスクリーニング法
|
|
EP3178944B1
(en)
|
2010-01-11 |
2019-05-15 |
Genomic Health, Inc. |
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
|
WO2011088163A1
(en)
|
2010-01-14 |
2011-07-21 |
President And Fellows Of Harvard College |
Methods for modulating skeletal remodeling and patterning by modulating shn2 activity, shn3 activity, or shn2 and shn3 activity in combination
|
|
EP2415877A3
(en)
*
|
2010-02-17 |
2012-02-15 |
Deutsches Krebsforschungszentrum |
Means and methods for diagnosing pancreatic cancer
|
|
WO2011106373A2
(en)
*
|
2010-02-24 |
2011-09-01 |
University Of Maryland, Baltimore |
Arnt isoform 3 as a predictor of aminoflavone responsiveness in cancer cells
|
|
ES2525382T3
(es)
|
2010-03-31 |
2014-12-23 |
Sividon Diagnostics Gmbh |
Método para la predicción de recurrencia del cáncer de mama bajo tratamiento endocrino
|
|
EP2558599A4
(en)
*
|
2010-04-14 |
2013-11-13 |
Nuvera Biosciences Inc |
METHOD FOR EVALUATING RESPONSE TO CANCER THERAPY
|
|
WO2011139721A1
(en)
|
2010-04-27 |
2011-11-10 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
|
WO2011140662A1
(en)
*
|
2010-05-13 |
2011-11-17 |
The Royal Institution For The Advancement Of Learning / Mcgill University |
Cux1 signature for determination of cancer clinical outcome
|
|
MX338883B
(es)
|
2010-07-27 |
2016-05-04 |
Genomic Health Inc |
Metodo para usar expresion de gen para determinar el pronostico de cancer de prostata.
|
|
WO2012040614A1
(en)
|
2010-09-23 |
2012-03-29 |
The Washington University |
Compositions and methods for detecting cancer metastasis
|
|
JP6230789B2
(ja)
|
2010-10-06 |
2017-11-15 |
中外製薬株式会社 |
癌幹細胞集団及びその作製方法
|
|
US20130267443A1
(en)
|
2010-11-19 |
2013-10-10 |
The Regents Of The University Of Michigan |
ncRNA AND USES THEREOF
|
|
US20130331381A1
(en)
*
|
2011-02-28 |
2013-12-12 |
Mcmaster University |
Treatment of Cancer WIth Dopamine Receptor Antagonists
|
|
BR112013021725A2
(pt)
|
2011-02-28 |
2016-11-01 |
Genentech Inc |
marcadores biológicos e métodos para prever resposta aos antagonistas de células b
|
|
JP6355555B2
(ja)
*
|
2011-04-01 |
2018-07-11 |
キアゲン |
Ｗｎｔ／ｂ−カテニンシグナル伝達経路に関する遺伝子発現シグネチャーおよびその使用
|
|
BR112013026199A2
(pt)
|
2011-04-15 |
2017-11-07 |
Compugen Ltd |
polipeptídeo isolado, proteína de fusão, sequência de ácidos nucleicos, vetor de expressão ou um vírus, célula recombinante, método de produção de um polipeptídeo com ectodomínio solúvel lsr, ou seu fragmento ou proteína de fusão, composição farmacêutica, uso de um anticorpo monoclonal ou policlonal ou um seu fragmento de ligação ao antígeno, uso do anticorpo ou do fragmento de ligação ao antígeno, uso de qualquer um de um polipeptídeo isolado, método de regulação por cima de citocinas, indução da expansão de células t, promoção da imunidade de células t específica antigênica e promoção da ativação das células t cd4+ e/ou cd8+ em um sujeito, método para potenciação de uma resposta imune secundária a um antígeno em um paciente, método de uso de pelo menos um de: um polipeptídeo isolado, método para tratamento ou prevenção de uma condição relacionada com o sistema imune, método para tratamento ou prevenção de uma doença infecciosa, método para diagnóstico de uma doença em um sujeito, método de produção de um polipeptídeo com ectodomínio solúvel tmem25, vsig10, ly6g6f, ou seu fragmento ou proteína de fusão, anticorpo monoclonal ou policlonal ou um seu fragmento de ligação ao antígeno, método de imunoterapia em um paciente e método para combinação de vacinação terapêutica com um antígeno em conjunto com a administração de qualquer um de um polipeptídeo
|
|
US20130064901A1
(en)
*
|
2011-04-18 |
2013-03-14 |
Agency For Science, Technology And Research |
Gene expression profiling for classifying and treating gastric cancer
|
|
BR112013027583A2
(pt)
*
|
2011-04-28 |
2016-09-06 |
Alexander Pearlman |
assinaturas genômicas de metástases em câncer de próstata
|
|
WO2012154567A2
(en)
*
|
2011-05-06 |
2012-11-15 |
Albert Einstein College Of Medicine Of Yeshiva University |
Human invasion signature for prognosis of metastatic risk
|
|
WO2012167101A1
(en)
*
|
2011-06-03 |
2012-12-06 |
The General Hospital Corporation |
Ovarian cancer stem cells and methods of isolation and uses thereof
|
|
EP2720721B1
(en)
|
2011-06-17 |
2017-08-30 |
President and Fellows of Harvard College |
Frizzled 2 as a target for therapeutic antibodies in the treatment of cancer
|
|
US20140141996A1
(en)
*
|
2011-06-22 |
2014-05-22 |
Oncocyte Corporation |
Methods and Compositions for the Treatment and Diagnosis of Cancer
|
|
KR101360409B1
(ko)
*
|
2011-07-11 |
2014-02-11 |
연세대학교 산학협력단 |
위암 암 줄기세포 특성에 기초한 위암의 치료용 타겟
|
|
WO2013023015A2
(en)
*
|
2011-08-11 |
2013-02-14 |
Albert Einstein College Of Medicine Of Yeshiva University |
Targets for diagnosis, prognosis and therapy of acute myeloid leukemia and myelodysplastic syndromes
|
|
JP6077997B2
(ja)
*
|
2011-09-07 |
2017-02-08 |
中外製薬株式会社 |
癌幹細胞の分離
|
|
CN103987861A
(zh)
|
2011-10-14 |
2014-08-13 |
加州大学评议会 |
皮肤鳞状细胞癌和假性上皮瘤样增生的基于多重pcr的测试及其区分方法
|
|
HK1212389A1
(en)
*
|
2011-10-24 |
2016-06-10 |
Signalchem Lifesciences Corporation |
Carbonic anhydrase ix-related markers and use thereof
|
|
WO2013063229A1
(en)
|
2011-10-25 |
2013-05-02 |
The Regents Of The University Of Michigan |
Her2 targeting agent treatment in non-her2-amplified cancers having her2 expressing cancer stem cells
|
|
US20140302511A1
(en)
|
2011-10-28 |
2014-10-09 |
Pharmalogicals Research Pte. Ltd. |
Cancer stem cell-specific molecule
|
|
WO2013071247A1
(en)
|
2011-11-10 |
2013-05-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Gene expression signatures of neoplasm responsiveness to theraphy
|
|
WO2013085482A1
(en)
*
|
2011-12-05 |
2013-06-13 |
Phigenix, Inc. |
Compositions and methods for monitoring and detecting cancerous conditions
|
|
EP2791359B1
(en)
|
2011-12-13 |
2020-01-15 |
Decipher Biosciences, Inc. |
Cancer diagnostics using non-coding transcripts
|
|
EP2794854B1
(en)
|
2011-12-23 |
2018-06-20 |
DePuy Synthes Products, Inc. |
Detection of human umbilical cord tissue-derived cells
|
|
WO2013102118A2
(en)
*
|
2011-12-30 |
2013-07-04 |
Anticancer, Inc. |
Imageable patient tumors in mice
|
|
KR20130081952A
(ko)
*
|
2012-01-10 |
2013-07-18 |
삼성전자주식회사 |
암 진단용 바이오마커 및 이를 이용한 암세포 분리 방법
|
|
WO2013109944A1
(en)
*
|
2012-01-18 |
2013-07-25 |
The Trustees Of The University Of Pennsylvania |
Methods for assessing risk for cancer using biomarkers
|
|
WO2013116537A1
(en)
*
|
2012-01-31 |
2013-08-08 |
Mount Sinai School Of Medicine |
A method to distinguish benign from malignant oncocytic cell tissue
|
|
US8725426B2
(en)
|
2012-01-31 |
2014-05-13 |
Genomic Health, Inc. |
Gene expression profile algorithm and test for determining prognosis of prostate cancer
|
|
SMT201700488T1
(it)
|
2012-02-15 |
2017-11-15 |
Novo Nordisk As |
Anticorpi che legano e bloccano il recettore d'innesco espresso sulle cellule mieloidi-1 (trem-1)
|
|
US9550830B2
(en)
|
2012-02-15 |
2017-01-24 |
Novo Nordisk A/S |
Antibodies that bind and block triggering receptor expressed on myeloid cells-1 (TREM-1)
|
|
JP6400480B2
(ja)
|
2012-02-15 |
2018-10-03 |
ノヴォ ノルディスク アー／エス |
ペプチドグリカン認識タンパク質１に結合する抗体
|
|
US9890429B2
(en)
*
|
2012-02-29 |
2018-02-13 |
Dana-Farber Cancer Institute, Inc. |
Compositions, kits, and methods for the identification, assessment, prevention, and therapy of cancer
|
|
US20150111758A1
(en)
*
|
2012-03-06 |
2015-04-23 |
Oslo Universitetssykehus Hf |
Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer
|
|
US9428813B2
(en)
|
2012-03-26 |
2016-08-30 |
The United States Of America, As Represented By The Secretary, Dept. Of Health & Human Services |
DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms
|
|
US20150064697A1
(en)
*
|
2012-03-29 |
2015-03-05 |
Health Research, Inc. |
P53 cooperation with dna methylation and suicidal interferon response to control silencing of repeats and ncrnas
|
|
EP2844769B1
(en)
*
|
2012-05-03 |
2019-07-24 |
Qiagen Sciences, LLC |
Gene expression signature for il-6/stat3 signaling pathway and use thereof
|
|
TWI454698B
(zh)
*
|
2012-05-22 |
2014-10-01 |
Glory Biomedical Co Ltd |
用於檢測腫瘤發生之腫瘤標誌、方法與套組
|
|
AU2013274389A1
(en)
|
2012-06-13 |
2015-01-22 |
Astrazeneca Ab |
Fixed dosage regimens for anti-type I interferon receptor (IFNAR) antibodies
|
|
JP2012196226A
(ja)
*
|
2012-06-19 |
2012-10-18 |
Nippon Kayaku Co Ltd |
癌幹細胞の培養方法、および癌幹細胞
|
|
NZ703411A
(en)
*
|
2012-06-27 |
2017-09-29 |
Berg Llc |
Use of markers in the diagnosis and treatment of prostate cancer
|
|
US9476099B2
(en)
|
2012-08-10 |
2016-10-25 |
Trustees Of Dartmouth College |
Method for determining sensitivity to decitabine treatment
|
|
DK3435084T3
(da)
|
2012-08-16 |
2023-05-30 |
Mayo Found Medical Education & Res |
Prostatakræftprognose under anvendelse af biomarkører
|
|
CA2884820A1
(en)
*
|
2012-09-14 |
2014-03-20 |
Memorial Sloan-Kettering Cancer Center |
Genes associated with dasatinib sensitivity
|
|
WO2014062218A1
(en)
*
|
2012-10-16 |
2014-04-24 |
University Of Southern California |
Colorectal cancer dna methylation markers
|
|
WO2014074805A1
(en)
|
2012-11-08 |
2014-05-15 |
Whitehead Institute For Biomedical Research |
Selective targeting of cancer stem cells
|
|
US10648035B2
(en)
|
2012-11-26 |
2020-05-12 |
The Johns Hopkins University |
Methods and compositions for diagnosing and treating gastric cancer
|
|
KR101467289B1
(ko)
*
|
2013-01-22 |
2014-12-02 |
한국원자력의학원 |
Ｗｄｆｙ3를 측정하는 제제를 포함하는 방사선 저항성 또는 민감성 진단용 조성물 및 이의 용도
|
|
KR101469917B1
(ko)
*
|
2013-01-22 |
2014-12-09 |
한국원자력의학원 |
Ｐｓａｐ를 측정하는 제제를 포함하는 방사선 저항성 또는 민감성 진단용 조성물 및 이의 용도
|
|
US20150376714A1
(en)
|
2013-02-01 |
2015-12-31 |
Sividon Diagnostics Gmbh |
Method for predicting the benefit from inclusion of taxane in a chemotherapy regimen in patients with breast cancer
|
|
US20160010059A1
(en)
*
|
2013-03-06 |
2016-01-14 |
The Regents Of The University Of California |
EXPANSION OF HEMATOPOIETIC PROGENITOR CELLS BY HISTONE METHYLTRANSFERASE G9a INHIBITION
|
|
US11976329B2
(en)
|
2013-03-15 |
2024-05-07 |
Veracyte, Inc. |
Methods and systems for detecting usual interstitial pneumonia
|
|
EP2796875B8
(en)
*
|
2013-04-23 |
2020-11-25 |
Albert-Ludwigs-Universität Freiburg |
Inhibitors of proteins specific for the secretome of a chondrocyte for use in the treatment of breast cancer metastasis
|
|
US10072300B2
(en)
*
|
2013-05-21 |
2018-09-11 |
Biomerieux |
Kit for the prognosis of colorectal cancer
|
|
JP2016521979A
(ja)
|
2013-05-30 |
2016-07-28 |
ジェノミック ヘルス， インコーポレイテッド |
腎臓がんを有する患者に対する再発スコアを計算するための遺伝子発現プロファイルアルゴリズム
|
|
US10190169B2
(en)
|
2013-06-20 |
2019-01-29 |
Immunexpress Pty Ltd |
Biomarker identification
|
|
PT3039424T
(pt)
*
|
2013-08-28 |
2020-09-03 |
Crown Bioscience Inc Taicang |
Assinaturas de expressão genética que permitem prever a resposta de um sujeito a um inibidor multiquinase e métodos de utilização do mesmo
|
|
CN105408751A
(zh)
*
|
2013-10-31 |
2016-03-16 |
Sk电信有限公社 |
用于诊断胰腺癌的组合物以及使用该组合物诊断胰腺癌的方法
|
|
US11047010B2
(en)
|
2014-02-06 |
2021-06-29 |
Immunexpress Pty Ltd |
Biomarker signature method, and apparatus and kits thereof
|
|
WO2015168255A1
(en)
|
2014-04-29 |
2015-11-05 |
Whitehead Institute For Biomedical Research |
Methods and compositions for targeting cancer stem cells
|
|
CA2947605A1
(en)
*
|
2014-05-13 |
2015-11-19 |
Bioatla, Llc |
Conditionally active biological proteins
|
|
CA2953459A1
(en)
*
|
2014-06-26 |
2015-12-30 |
Institute For Systems Biology |
Markers and therapeutic indicators for glioblastoma multiforme (gbm)
|
|
US12297505B2
(en)
|
2014-07-14 |
2025-05-13 |
Veracyte, Inc. |
Algorithms for disease diagnostics
|
|
EP3172232B1
(en)
|
2014-07-17 |
2023-12-27 |
Novo Nordisk A/S |
Site directed mutagenesis of trem-1 antibodies for decreasing viscosity.
|
|
CN120137055A
(zh)
*
|
2014-07-17 |
2025-06-13 |
恺兴生命科技(上海)有限公司 |
靶向cld18a2的t淋巴细胞及其制备方法和应用
|
|
US10329323B2
(en)
*
|
2014-07-25 |
2019-06-25 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Method for purifying antibodies using PBS
|
|
EP3215170A4
(en)
|
2014-11-05 |
2018-04-25 |
Veracyte, Inc. |
Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data
|
|
US10655185B2
(en)
|
2014-11-10 |
2020-05-19 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Methods for diagnosis and prognosis of epithelial tumors
|
|
WO2016090323A1
(en)
*
|
2014-12-05 |
2016-06-09 |
Prelude, Inc. |
Dcis recurrence and invasive breast cancer
|
|
SG10202012249YA
(en)
|
2014-12-08 |
2021-01-28 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
|
US20160168647A1
(en)
*
|
2014-12-11 |
2016-06-16 |
Worcester Polytechnic Institute |
Characterization of pre-cancer biomarker for prognostic screen
|
|
US11213598B2
(en)
*
|
2015-11-12 |
2022-01-04 |
The Board Of Trustees Of The Leland Stanford Junior University |
Labeled probe and methods of use
|
|
WO2017096458A1
(en)
*
|
2015-12-07 |
2017-06-15 |
Ontario Institute For Cancer Research (Oicr) |
Immune gene signature predictive of anthracycline benefit
|
|
CA3008434A1
(en)
*
|
2015-12-14 |
2017-06-22 |
Rowan University |
Early-stage alzheimer's disease autoantibody biomarkers, target antigens, and diagnostic uses thereof
|
|
EP3504348B1
(en)
|
2016-08-24 |
2022-12-14 |
Decipher Biosciences, Inc. |
Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
|
|
US10487365B2
(en)
|
2016-09-20 |
2019-11-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for detecting expression of lnc-FANCI-2 in cervical cells
|
|
JP7595413B2
(ja)
|
2016-11-30 |
2024-12-06 |
ケース ウエスタン リザーブ ユニバーシティ |
１５－ｐｇｄｈ阻害剤とコルチコステロイドおよび／またはｔｎｆ阻害剤との組み合わせならびにその使用
|
|
KR102014951B1
(ko)
|
2017-01-06 |
2019-08-27 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
EP3571322B9
(en)
|
2017-01-20 |
2023-10-04 |
VERACYTE SD, Inc. |
Molecular subtyping, prognosis, and treatment of bladder cancer
|
|
WO2018145080A1
(en)
|
2017-02-06 |
2018-08-09 |
Case Western Reserve University |
Compositions and methods of modulating short-chain dehydrogenase activity
|
|
CA3054083A1
(en)
*
|
2017-02-20 |
2018-08-23 |
The Regents Of The University Of California |
Serologic assay for silent brain ischemia
|
|
EP3593140A4
(en)
|
2017-03-09 |
2021-01-06 |
Decipher Biosciences, Inc. |
SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY
|
|
WO2018175749A2
(en)
|
2017-03-22 |
2018-09-27 |
Children's Medical Center Corporation |
Lrp1 binding agents and uses thereof
|
|
CN110691606A
(zh)
|
2017-03-22 |
2020-01-14 |
儿童医学中心公司 |
Prss2抑制
|
|
CA3062716A1
(en)
|
2017-05-12 |
2018-11-15 |
Decipher Biosciences, Inc. |
Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness
|
|
US11217329B1
(en)
|
2017-06-23 |
2022-01-04 |
Veracyte, Inc. |
Methods and systems for determining biological sample integrity
|
|
WO2019014663A1
(en)
*
|
2017-07-14 |
2019-01-17 |
Dana-Farber Cancer Institute, Inc. |
MODULATION OF BIOMARKERS TO INCREASE ANTI-TUMOR IMMUNITY AND IMPROVE THE EFFECTIVENESS OF CANCER IMMUNOTHERAPY
|
|
WO2019014664A1
(en)
*
|
2017-07-14 |
2019-01-17 |
Dana-Farber Cancer Institute, Inc. |
MODULATION OF BIOMARKERS TO INCREASE ANTITUMOR IMMUNITY AND IMPROVE THE EFFECTIVENESS OF ANTICANCER IMMUNOTHERAPY
|
|
WO2019018537A1
(en)
*
|
2017-07-18 |
2019-01-24 |
Exosome Diagnostics, Inc. |
NUCLEIC ACID SEQUENCING ASSOCIATED WITH EXOSOMAL ISOLATION IN PATIENTS WITH MULTIPLE GLIOBLASTOMA
|
|
WO2019028285A2
(en)
|
2017-08-04 |
2019-02-07 |
Genomedx, Inc. |
USE OF SPECIFIC GENE EXPRESSION OF IMMUNE CELLS FOR THE PROGNOSIS OF PROSTATE CANCER AND THE PREDICTION OF SENSITIVITY TO RADIOTHERAPY
|
|
WO2019041045A1
(en)
|
2017-09-01 |
2019-03-07 |
The Hospital For Sick Children |
PROFILING AND TREATMENT OF HYPERMUTANT CANCER
|
|
EP3679160A4
(en)
|
2017-09-08 |
2021-05-19 |
Myriad Genetics, Inc. |
METHOD OF USING BIOMARKERS AND CLINICAL VARIABLES TO PREDICT THE BENEFIT OF CHEMOTHERAPY.
|
|
KR102230314B1
(ko)
*
|
2017-10-24 |
2021-03-22 |
주식회사 메드팩토 |
혈액으로부터 암을 진단하는 방법
|
|
KR102141997B1
(ko)
|
2017-11-22 |
2020-08-06 |
(주)인핸스드바이오 |
Pmvk를 유효성분으로 포함하는 방사선 저항성 암 진단용 또는 방사선 치료 예후 예측용 바이오마커 조성물
|
|
WO2019103456A2
(ko)
*
|
2017-11-22 |
2019-05-31 |
울산대학교 산학협력단 |
Pmvk를 유효성분으로 포함하는 방사선 저항성 암 진단용 또는 방사선 치료 예후 예측용 바이오마커 조성물
|
|
CN109837342A
(zh)
*
|
2017-11-28 |
2019-06-04 |
立森印迹诊断技术（无锡）有限公司 |
一种用于检测乳腺肿瘤良恶性程度的分级模型及其应用
|
|
KR20200106495A
(ko)
|
2017-11-29 |
2020-09-14 |
보오드 오브 리젠츠, 더 유니버시티 오브 텍사스 시스템 |
암 치료요법을 위한 조성물 및 방법
|
|
EP3754336B1
(en)
*
|
2018-02-15 |
2024-01-17 |
3-D Matrix, Ltd. |
Cancer lesion tissue evaluation for optimizing effect of boron neutron capture therapy
|
|
EP3774902A1
(en)
|
2018-04-02 |
2021-02-17 |
Bristol-Myers Squibb Company |
Anti-trem-1 antibodies and uses thereof
|
|
US20190381500A1
(en)
*
|
2018-06-14 |
2019-12-19 |
Daisuke Takagi |
Cell contained container and cell contained container producing method, and cell chip
|
|
WO2020056338A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
|
US12331320B2
(en)
|
2018-10-10 |
2025-06-17 |
The Research Foundation For The State University Of New York |
Genome edited cancer cell vaccines
|
|
CN120463721A
(zh)
|
2018-11-21 |
2025-08-12 |
卡斯西部储备大学 |
调节短链脱氢酶活性的组合物和方法
|
|
CN109321658B
(zh)
*
|
2018-11-23 |
2021-09-07 |
浙江大学 |
一种检测宫颈癌易感性的试剂盒
|
|
CN109628570A
(zh)
*
|
2018-12-07 |
2019-04-16 |
南方医科大学南方医院 |
一种检测TRIM29基因Tyr544Cys突变的试剂盒及其用途
|
|
CN109680005A
(zh)
*
|
2019-01-14 |
2019-04-26 |
广州市妇女儿童医疗中心 |
Wdr12基因在脑胶质瘤细胞的抑制和凋亡中的应用
|
|
CN110082529B
(zh)
*
|
2019-03-11 |
2022-04-19 |
南方医科大学深圳医院 |
一种肿瘤细胞表面标志物及其应用
|
|
CN110108878A
(zh)
*
|
2019-05-30 |
2019-08-09 |
四川大学华西医院 |
Eif2s1自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
|
|
CN110412269A
(zh)
*
|
2019-06-26 |
2019-11-05 |
四川大学华西医院 |
Ndn自身抗体检测试剂在制备肺癌筛查试剂盒中的用途
|
|
WO2021026335A1
(en)
*
|
2019-08-08 |
2021-02-11 |
The Trustees Of Indiana University |
Methods for identifying and treating urinary tract infections
|
|
KR102055872B1
(ko)
|
2019-08-20 |
2019-12-13 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
US20240131204A1
(en)
*
|
2019-10-10 |
2024-04-25 |
Cellectar Biosciences, Inc. |
Fractionated Dosing of a Phospholipid Ether Analog for the Treatment of Cancer
|
|
KR102168498B1
(ko)
|
2019-12-09 |
2020-10-21 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
CN111073979B
(zh)
*
|
2019-12-31 |
2021-08-17 |
上海交通大学 |
阻断ccl28趋化通路的胃癌治疗方法
|
|
CN111394334B
(zh)
*
|
2020-01-10 |
2022-02-15 |
中山大学 |
抑制ezh2活性的抗肿瘤多肽及其应用
|
|
EP4157312A4
(en)
*
|
2020-05-27 |
2024-07-31 |
Baylor College of Medicine |
COMPOSITIONS AND METHODS FOR TREATING NEOVASCULARIZATION AND ISCHEMIC RETINOPATHIES BY TARGETING ANGIOGENESIS AND CHOLESTEROL TRANSPORT
|
|
CN113827727B
(zh)
*
|
2020-06-24 |
2025-04-29 |
上海交通大学医学院附属瑞金医院 |
Ptpn2抑制剂在kras突变肿瘤中的应用
|
|
JP7619556B2
(ja)
*
|
2020-10-08 |
2025-01-22 |
藤倉化成株式会社 |
動脈病変を検出し、並びに、脳心臓血管障害、糖尿病、慢性腎臓病、又は固形癌を検出する、体液抗体バイオマーカー
|
|
KR102185037B1
(ko)
|
2020-10-14 |
2020-12-01 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
CN112522401B
(zh)
*
|
2020-11-16 |
2021-09-24 |
北京大学人民医院 |
Tox3基因过表达作为肝癌预后标志物中的应用
|
|
KR102205224B1
(ko)
|
2020-11-24 |
2021-01-20 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
TR202021768A1
(tr)
*
|
2020-12-25 |
2022-07-21 |
Univ Istanbul Medipol |
Gli̇oma beyi̇n tümörünün hasta serumlarindan tespi̇ti̇ne yöneli̇k anti̇-slc3a2 otoanti̇korlarinin ve slc3a2?ni̇n kullanildiği yöntemler
|
|
KR102221671B1
(ko)
|
2021-01-13 |
2021-03-02 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
CN112980952B
(zh)
*
|
2021-02-05 |
2022-11-29 |
中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） |
用于预测异柠檬酸脱氢酶1基因野生型胶质瘤预后与抗pd1治疗疗效的标志物及其应用
|
|
KR102260250B1
(ko)
|
2021-02-22 |
2021-06-03 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
KR102243705B1
(ko)
|
2021-02-22 |
2021-04-23 |
강원대학교산학협력단 |
P53의 전사적 활성 저해에 의한 암 검출용 바이오마커, 키트 또는 조성물, 이를 이용한 정보 제공 방법, 약물 스크리닝 방법, 및 악성 형질전환 모델
|
|
CN113063944B
(zh)
*
|
2021-03-05 |
2023-03-24 |
李朴 |
血清gsdme在b淋巴细胞白血病诊断、疗效监测及预后评估上的用途
|
|
US20240240189A1
(en)
*
|
2021-04-08 |
2024-07-18 |
City Of Hope |
Cancer treatment by targeting proteins or interactions of ephrinb-rgs3-kif20a-sept7 axis
|
|
CN113278057B
(zh)
*
|
2021-04-23 |
2023-05-26 |
中国人民解放军海军军医大学 |
一种维甲酸诱导蛋白16特异性多克隆抗体的制备和应用
|
|
HRP20231255T1
(hr)
|
2021-04-23 |
2024-02-02 |
Astrazeneca Ab |
Režim doziranja anti-ifnar1 za potkožnu injekciju
|
|
EP4374172A4
(en)
*
|
2021-07-21 |
2025-05-14 |
Mercy Bioanalytics, Inc. |
COMPOSITIONS AND METHODS FOR DETECTING BREAST CANCER
|
|
CN113916754B
(zh)
*
|
2021-10-12 |
2023-11-10 |
四川大学华西医院 |
用于检测乳腺癌患者循环肿瘤细胞的细胞表面标志物及应用
|
|
CN113633778B
(zh)
*
|
2021-10-18 |
2022-01-07 |
广州医科大学附属肿瘤医院 |
Bex2在制备热化疗耐药胃癌增敏药物或制备预测疗效产品的应用
|
|
CN114350799A
(zh)
*
|
2021-12-28 |
2022-04-15 |
深圳市人民医院 |
Htr2c在低级别胶质瘤的预后中的应用
|
|
CN114940714B
(zh)
*
|
2022-05-20 |
2023-06-16 |
湖南师范大学 |
肝癌标志物soat1单克隆抗体制备及其应用
|
|
CN115786501B
(zh)
*
|
2022-07-02 |
2023-06-16 |
武汉大学 |
一种与结直肠癌早期筛查和辅助诊断相关的增强子功能位点及其应用
|
|
CN115976203B
(zh)
*
|
2022-08-25 |
2023-08-01 |
威海市立医院 |
Hap1在制备诊断、预防和/或治疗胃癌的产品中的应用
|
|
EP4606896A1
(en)
*
|
2022-10-18 |
2025-08-27 |
NB Health Laboratory Co. Ltd. |
Antibody, nucleic acid, cell, and pharmaceutical
|
|
CN115873798A
(zh)
*
|
2022-11-15 |
2023-03-31 |
重庆医科大学附属儿童医院 |
一种抗CD24 scFv靶向修饰的类外泌体的新型药物载体的制备方法
|
|
CN117192122B
(zh)
*
|
2023-10-08 |
2025-02-11 |
山东大学齐鲁医院 |
一种预测肝内胆管癌预后及培美替尼治疗效果的生物标志物及其应用
|
|
CN117343932B
(zh)
*
|
2023-12-06 |
2024-03-22 |
中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） |
靶向抑制MS4A7基因表达的siRNA及其应用
|
|
CN117487923B
(zh)
*
|
2023-12-27 |
2024-05-31 |
湖南家辉生物技术有限公司 |
Habp2基因突变体作为检测靶点的应用、具有其的检测试剂和/或检测试剂盒
|
|
CN120044256A
(zh)
*
|
2025-02-11 |
2025-05-27 |
中国人民解放军总医院第七医学中心 |
载脂蛋白apod缺失作为诊断宫颈癌分子标志物的应用
|
|
CN119916024B
(zh)
*
|
2025-04-02 |
2025-06-17 |
浙江大学 |
Smurf2蛋白或其编码基因作为靶点在制备抗肿瘤药物中的应用
|